Tissue concentration of clindamycin and gentamicin near ischaemic ulcers with transvenous injection in Bier's arterial arrest

Lancet

Volumn 348, Issue 9030, 1996, Pages 781-783

  Burgmann, Heinz ^b   Georgopoulos, Apostolos ^b   Graninger, Wolfgang ^b   Koppensteiner, Renate ^b   Maca, Thomas ^b   Minar, Erich ^b   Schneider, Barbara ^b   Stümpflen, Andreas ^b   Ehringer, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; GENTAMICIN;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; FOOT ULCER; HUMAN; HUMAN TISSUE; INJECTION; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030596905     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07089-4     Document Type: Article

References (21)

1. Grunfeld C. Diabetic foot ulcers: etiology, treatment, and prevention. Adv Intern Med 1992; 37: 103-32.
2. Hild R. Klinik der diabetischen Makroangiopathie. In: Alexander K, Cachovan M, eds. Diabetische Angiopathien, G Witzstrock, 1977: 150-63.
3. Lassen NA. General discussion on occlusive arterial disease in diabetes mellitus. Scand J Clin Lab Invest 1973; 31/Sup 128: 235-37.
4. Bollinger A. Internistische Behandlung peripherer arterieller Durchblutungsstörungen. Schweiz Med Wschr 1970; 100: 774-77.
5. Hild R. Prevention and therapy of ischemic tissue lesions. Stage IV of arterial occlusive disease, Dtsch Med F, 1967; 18: 329-32.
6. Amendt K, Rexroth W, Römmele U, Stein U, Wagner E, Hild R Intraarterielle Injektion von Mezlocillin bei arterieller Verschluszkrankheit im Stadium IV. Vasa. 16:1987;193-200.
7. Metz W, Ruf W, Maeder M, Sonntag HG. Die intraarterielle Antibiotikatherapie mit Cefotaxim bei Osteitis. XVIII Weltkongress, Societe Internationale de Chirurgie Orthopedique et de Traumatologie 1987; München.
8. Schoop W, Acevedo A Concentration of antibiotics after intravenous and after retrograde intravenous injection. Wiener Medizinische Wochenschrift. 718:1993;199-200.
9. Acevedo A, Schoop W, Schnell A, Toledo L. Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route. Rev Med Chil 1990; 118: 881-88.
10. Partsch H. Bier's occlusion. An unjustly neglected therapeutic possibility in resistant tissue defects of the extremities. Acta Med Austriaca. 17:1990;35-39.
11. Seidel C, Richter UG, Buhler S, Hornstein OP. Drug therapy of diabetic neuropathic foot ulcers: transvenous retrograde perfusion versus systemic regimen. Vasa 1991; 20: 388-93.
12. Seidel C, Buhler Singer S, Tacke J, Hornstein OP Therapeutic superiority of regional retrograde venous antibiotic pressure infusion versus systemic venous infusions in diabetic patients with infected neuropathic plantar ulcers. Hautarzt. 45:1994;74-79.
13. Mawer GE, Ahmad R, Dobbs SM, McGough JG, Lucas SB, Tooth JA Prescribing aids for gentamicin. Br J Clin Pharmac. I:1974;45-50.
14. Georgopoulos A. A simple micro agar diffusion method for the determination of antibiotic concentrations in blood and other body fluids. Zentralblatt für Bakteriologie 1979; A242: 387-93.
15. Acevedo A, Schoop W. Claforan concentration in wound secretion following intravenous, intra-arterial, and regional intravenous infusion in patients with stage IV arterial occlusive diseases of the lower extremities. Vasa Suppl 1991; 32: 363-64.
16. Frimodt-Moller N, Bentzon MW, Thomsen VF. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis 1986; 154: 511-17.
17. Ingermann MJ, Pitsakis PG, Rosenberg AF, Levison ME. The importance of pharmacodynamics in determining the dosing interval in therapy for experimental Pseudomonas aeruginosa endocarditis in the rat. J Infect Dis 1986; 153: 707-14.
18. Bartlett JG, Black RJ, Brook I, Ehrenfeld M, Eschenbach DA. Zambrano D, ed. Clindamycin in the treatment of human infections, Michigan: The Upjohn Company, 1992.
19. Nilsson L, Maller R, Ansehn S. Inhibition of Aminoglykoside Activity by Heparin. Antimicrob Agents Chemother 1981; 20: 155-58.
20. Sewell DL, Golper TA, Brown SD, Nelson E, Knower M, Kimbrough RC. Stability of single and combination antimicrobial agents in various dialysates in the presence of insulin and heparin. Am J Kidney Dis 1983; 3: 209-12.
21. Partsch H, Jochmann W, Mostbeck A, Hirschl M. Nuclearmedical Investigations on Tissue Concentration and Hemodynamic Effects of Retrograde Intravenous Pressure Infusions. WMW 1993; 718: 172-76.